Table 3.

Patient medication

	Patient no.	Pre-FUS l -dopa equivalents (mg/day)	3 months post-FUS l -dopa equivalents (mg/day)	Pre-FUS dopamine agonists (mg/day)	3 months post-FUS dopamine agonists (mg/day)
Group 1	1	1,000	1,000	Ropinirol: 3	Ropinirol: 3
				Amantadine: 300	Amantadine: 300
				Biperiden: 4	Biperiden: 4
	2	800	800	-	-
	3	300	-	-	-
	4	600	600	Biperiden: 6	-
Group 2	5	1,000	-	-	-
	6	1,000	-	-	-
	7	1,200	600	Ropinirol: 2	Ropinirol: 2
	8	-	-	-	-
	9	600	1,000	Rotigotine: 8	-
	10	1,000	600	Ropinirol: 10	-
	11	-	-	Amantadine: 1,000	Amantadine: 600
	12	800	800	Ropinirol: 4	Ropinirol: 4
	13	800	500	Amantadine: 300	Amantadine: 300
				Entacapone: 1,600	Entacapone: 1,000
Mean		827	536

Pre- and postoperative antiparkinsonian medication. Patients 8 and 11 had stopped their l-dopa intake long before the intervention. Mean intakes of l-dopa equivalents were calculated over 11 patients.